CN1159028C - Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin - Google Patents

Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin Download PDF

Info

Publication number
CN1159028C
CN1159028C CNB001345761A CN00134576A CN1159028C CN 1159028 C CN1159028 C CN 1159028C CN B001345761 A CNB001345761 A CN B001345761A CN 00134576 A CN00134576 A CN 00134576A CN 1159028 C CN1159028 C CN 1159028C
Authority
CN
China
Prior art keywords
chinese medicine
radix
caused
radix notoginseng
prothrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001345761A
Other languages
Chinese (zh)
Other versions
CN1299661A (en
Inventor
刘汉春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001345761A priority Critical patent/CN1159028C/en
Publication of CN1299661A publication Critical patent/CN1299661A/en
Application granted granted Critical
Publication of CN1159028C publication Critical patent/CN1159028C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to Chinese medicine for treating various hemorrhagic diseases caused by prothrombin reduction, which is composed of traditional Chinese medicine, i.e. 30 to 50% of panax pseudo-ginseng and 70 to 50 % of fructus amomi, spikenard, hairy vein agrimonia herd and raw milk vetch root, wherein the panax pseudo-ginseng is main medicine, and the rest are secondary medicine. Proved by clinical experience for more than 40 years, the Chinese medicine of the present invention has the advantages of particular therapeutic effect, easy production, short treatment course, obvious effects, no recurrence and no poisonous effect, and has particular therapeutic effects on various bleeding diseases (comprising nosebleed, gum bleeding, skin bleeding, hematemesis, hemafecia, visceral hemorrhage and gynecologic blood diseases) caused by the prothrombin reduction in the current treatment of blood diseases.

Description

A kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin
The invention belongs to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin.
At present, it is a kind of difficult hematopathy that the thrombinogen that Different types of etiopathogenises causes reduces hemorrhage, and this disease morbidity is anxious, and the course of disease is short, is more common in child and youth.This disease bleeding part is extensive, as: skin petechia, ecchymosis, purpura, hematoma, epistaxis, bleeding from the gum, oral cavity and conjunctival hemorrhage etc., severe patient have visceral hemorrhage even intracranial hemorrhage and cause death.Such is sick clinically sees more, and the mortality rate height belongs in the hematopathy difficult and complicated illness than refractory.
The object of the present invention is to provide a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin, it can address the above problem preferably, is a kind of new medicine for the treatment of hemorrhage.
Technical scheme of the present invention: a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin, it is made up of following Chinese medicine:
Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 30-50%, and all the other ministerial drug proportions are 70-50%.
Still can add Endoconcha Sepiae in the above-mentioned said ministerial drug, its addition can be the 20-30% of total amount.
Above-mentioned said Chinese medicine such as patient have pathogenic heat concurrently, but also in the compatibility nourishing YIN and clearing away heat antidotal medicament close clothes.
The dosage form of above-mentioned said Chinese medicine is: honeyed pill, the watered pill or grind impalpable powder altogether and go into capsule.
Above-mentioned said usage of Chinese materia medica is every day three times, and each three grams are to six grams, one hour after meal warm water delivery service.
Pharmacology of the present invention explanation: the traditional Chinese medical science thinks that blood is to be drawn by digestive organs that nutrient liberalization life in the food forms and the heart, liver, spleen have substantial connection, so have the inclination the saying of main blood, blood stored in the liver, The spleen governs the blood.The various functional activities of human body all depend on blood nutrition are provided, and gas and blood are unified integral body, the blood whole body of in blood vessel, circulating, and the one, move by the promotion of gas, the 2nd, the effect of taking the photograph is not overflowed outside the blood vessel blood by the receipts of gas.If the essence of water and grain generation blood of deficiency of spleen-QI in can not pickuping food, the blood because deficiency of spleen-QI can not be united is received and is taken the photograph the various bleedings that mistake department just causes clinical findings simultaneously.
Radix Notoginseng: the key medicine of stopping blooding in the Chinese medicine, apply to the inside and outside various hemorrhages of human body, get its hemostasis and do not stay the characteristic of the stasis of blood;
Fructus amomi: the merit of getting the gas of its row of being amusing;
Radix Et Rhizoma Nardostachyos: get it and dredge the capable spleen of smooth mechanism of qi dissipating depression of QI; More than the mutual potentiation of two flavors rouse oneself spleen sun effect to reach;
Herba Agrimoniae: getting its astringing to arrest bleeding and Radix Notoginseng compatibility is the effect of potentiation hemostatic;
Radix Astragali: get the strong temper effect of its beneficial vigour;
Endoconcha Sepiae: get that it is astringent or styptic treatment for spontaneous sweating, convergence, hemostasis.
With the various hemorrhagic disease of treatment behind the first-class herbal medicine compatibility, hemostasis takes stopgap measures, the QI invigorating of being amusing, and the function of having blood under one's command of enhancing spleen is to reach treating both the principal and secondary aspects of a disease.
Clinical case efficacy analysis of the present invention:
1, Zhao XX, man, 46 years old now; live Bei Tan township, Baodi county, 74 year spring be because of suffering from the heavy cold hyperpyrexia, is diagnosed as acute leukemia through Ji County hospital that garrisons of county hospital army; the clinical skin nosebleed that occurs, and has blood in stool, and the hyperpyrexia state of an illness is critical; can not hospitalization because of the family financial situation difficulty, and through adopting above-mentioned said Chinese medicinal capsule compatibility heat-clearing and toxic substances removing powder, two weeks cured; existing married through paying a return visit, and two girls were arranged; healthy, and existing I do manual work in Tianjin, do building.
2, Qu Xifang, the man, 33 years old now, live Tianjin Children's Hospital because of nose bleeding merges anemia incessantly 75 year spring, make a definite diagnosis the aleucia acute attack, chemically examined situation hematochrome 5g at that time, platelet 4000 (normal value 10-30 ten thousand) is given treatment to curative effect in many ways through hospital and is not shown the notice of being critically ill down, after adopt above-mentioned said Chinese medicinal capsule medical treatment to pull through in one month, cure the back and do not have recurrence, it is qualified to have a physical examination after graduating from the middle school, and is on active service the Tianjin People's Armed Police, has now demobilized and married, give birth to boy's health, existing I work in Tianjin Railway Area branch office.
3, Gao Ruina, woman, 25 years old now, 83 years once because of the extremity large tracts of land purpura appearred, return toward Tianjin second gynecological of hospital emergency treatment, after accept for medical treatment, through blood test platelet number 6000, make a definite diagnosis the aleukia purpura, invalid through hospital's hormone transfusion and a large amount of haemostatic medicament therapy, skin nosebleed area increases, and hospital notifies family members to be critically ill, speed is with above-mentioned said Chinese medicinal capsule, through treating the recovery from illness of 1 wheat harvesting period.Existing married, there is not recurrence over healthy 17 years.Now be operated in the blue or green power plant of Tianjin willow.
4, Li Chunfeng, the woman, 43 years old now, 76 years more than because of two lower limb large tracts of land ecchymosiss gingival hemorrhage of holding concurrently, and is aleucia through the chemical examination of Tianjin hematopathy institute, platelet is 5000, in many ways fail to respond to any medical treatment through this institute's Chinese and western medicine, chronic aleucia (state of an illness show effect repeatedly reach half a year many) occurs transferring to behind the anemia, through curing recovery from illness in two months with above-mentioned said Chinese medicinal capsule, pay a return visit healthyly, existing work unit is Tianjin Electricity Generating Equipment Factory.
5, Zhang Chunli, man, 22 years old now, 99 years more than because of the gingiva oozing of blood, and conjunctival congestion, right lower extremity have the big stasis of blood scar of palm, right deradenoncus was once just controlled the Tianjin traditional Chinese medical science one attached institute, chemical examination situation platelet count 8200, be diagnosed as aleucia, hemorrhage waiting looked into, through then cure recovery from illness in nearly two months with above-mentioned said Chinese medicinal capsule, in in February, 2000 through national units concerned medical fitness, send France to and study abroad, appear body health, the work and study All going well through return visit.
Superiority of the present invention is: year clinical experience checking surplus in the of long-pending 40, it is special that this medication is imitated, make simple, short treating period after the medication, instant effect, do not have recurrence, toxic effects is in a kind of current treatment hematopathy because thrombinogen reduces the Chinese medicine that the various hemorrhagic disease that caused (comprise that epistaxis, bleeding from the gum, skin are defeated in battle, spit blood, are had blood in stool, the anovulatory dysfunctional uterine hemorrhage disease of visceral hemorrhage and gynecological etc.) have special efficacy.
Embodiment 1: a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin, and it is made up of following Chinese medicine:
Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 30%, and all the other ministerial drug proportions are 70%.
Add Endoconcha Sepiae in the above-mentioned said ministerial drug, its addition can be 25% of total amount.
Above-mentioned said Chinese medicine such as patient have pathogenic heat concurrently, but also in the compatibility nourishing YIN and clearing away heat antidotal medicament Baihu Tang close clothes.
The dosage form of above-mentioned said Chinese medicine is gone into capsule for grinding impalpable powder altogether.
Embodiment 2: a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin, and it is made up of following Chinese medicine:
Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 50%, and all the other ministerial drug proportions are 50%.
Add Endoconcha Sepiae in the above-mentioned said ministerial drug, its addition can be 20% of total amount.
Above-mentioned said Chinese medicine such as patient have pathogenic heat concurrently, but also in the compatibility nourishing YIN and clearing away heat antidotal medicament qingying decoction close clothes.
The dosage form of above-mentioned said Chinese medicine is gone into capsule for grinding impalpable powder altogether.

Claims (5)

1, a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin is characterized in that it is made up of following Chinese medicine:
Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 30-50%, and all the other ministerial drug proportions are 70-50%.
2, according to the said a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin of claim 1, it is characterized in that adding Endoconcha Sepiae in the said ministerial drug, its addition can be the 20-30% of total amount.
3, according to the said a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin of claim 1, it is characterized in that the dosage form of said Chinese medicine is: honeyed pill, the watered pill or grind impalpable powder altogether and go into capsule.
4,, it is characterized in that it is made up of following Chinese medicine: Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali according to the said a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin of claim 1; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 30%, and all the other ministerial drug proportions are 70%; Add Endoconcha Sepiae in the said ministerial drug, its addition can be 25% of total amount.
5,, it is characterized in that it is made up of following Chinese medicine: Radix Notoginseng, fructus amomi, Radix Et Rhizoma Nardostachyos, Herba Agrimoniae, Radix Astragali according to the said a kind of Chinese medicine for the treatment of the various hemorrhages of caused by reduced prothrombin of claim 1; Wherein Radix Notoginseng is a monarch drug, and all the other are ministerial drug, and the Radix Notoginseng proportion is 50%, and all the other ministerial drug proportions are 50%; Add Endoconcha Sepiae in the said ministerial drug, its addition can be 20% of total amount.
CNB001345761A 2000-12-13 2000-12-13 Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin Expired - Fee Related CN1159028C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001345761A CN1159028C (en) 2000-12-13 2000-12-13 Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001345761A CN1159028C (en) 2000-12-13 2000-12-13 Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin

Publications (2)

Publication Number Publication Date
CN1299661A CN1299661A (en) 2001-06-20
CN1159028C true CN1159028C (en) 2004-07-28

Family

ID=4596291

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001345761A Expired - Fee Related CN1159028C (en) 2000-12-13 2000-12-13 Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin

Country Status (1)

Country Link
CN (1) CN1159028C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101023780B1 (en) 2009-02-23 2011-03-21 주식회사한국전통의학연구소 Composition for preventing and treating acute pancreatitis comprising Nardostachys jatamansi extract as an active ingredient

Also Published As

Publication number Publication date
CN1299661A (en) 2001-06-20

Similar Documents

Publication Publication Date Title
CN100382839C (en) Chinese-medicinal composition for treating coronary heart disease
CN103330805A (en) Traditional Chinese medicine composition for treating menorrhagia
CN101829296B (en) Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof
CN102813839A (en) Compound medicine for treating cluster headache syndrome
CN102552734B (en) Gargle for treating dental ulcer
CN1159028C (en) Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin
CN102552736A (en) Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura
CN102319376B (en) Chinese herbal medicament for treating nephropathy
CN1506107A (en) Chinese medicine for treatnig hemorrhagic diseases caused by reduced serozyme
CN102198182A (en) Medicament for treatment of interstitial pneumonia
CN1616041A (en) Chinese medicine composition for treating chronic ulcerative colitis
CN102008554B (en) Chinese medicinal mixture for treating upper gastrointestinal bleeding
CN100411672C (en) A medicinal composition for treatment of psoriasis
CN104800491A (en) Oral solution with superstrong function of improving human immunity
CN104435545A (en) Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning
CN104474173B (en) A kind of medicine for treating facioplegia
CN104117018A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN103585471B (en) Traditional Chinese medicine composition for treating thrombocytopenia
CN100360154C (en) Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease
CN103751355B (en) A kind of have the pharmaceutical composition promoting leukocyte effect
CN102552755A (en) Traditional Chinese medicine composition for treating aplastic anemia
CN100594914C (en) Medicine for curing coronary heart disease
CN102114211A (en) Chinese herbal medicine for treating hepatopathy
CN101537068B (en) Chinese medicine for treating angina
CN1823960A (en) Traditional Chinese medicine for treating hemorrhoid

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee